Investigating how dietary nutrients affect kidney disease progression and genetic risk
The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy
This study is looking at how the amount of salt and potassium in your diet affects the progression of chronic kidney disease, especially for people with certain genetic risks, to help create better dietary advice for those who need it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10808880 on NIH RePORTER |
What this research studies
This research focuses on understanding the impact of dietary factors, particularly sodium and potassium, on the progression of chronic kidney disease (CKD) and apolipoprotein L1 nephropathy, especially among individuals with specific genetic risk variants. The study aims to design prospective studies that will analyze how these dietary elements influence CKD outcomes in both low- and adequately-resourced settings. By leveraging advanced biostatistical methods and genetic epidemiology, the research seeks to provide insights that could lead to tailored dietary recommendations for at-risk populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals of African descent with chronic kidney disease, particularly those carrying the APOL1 risk variants.
Not a fit: Patients without chronic kidney disease or those not of African descent may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved dietary guidelines that help slow the progression of kidney disease in genetically predisposed individuals.
How similar studies have performed: Previous research has shown promising results in understanding the role of dietary factors in kidney disease, making this approach both relevant and potentially impactful.
Where this research is happening
Boston, United States
- Boston Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Ilori, Titilayo Omolara — Boston Medical Center
- Study coordinator: Ilori, Titilayo Omolara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.